Septins and Human Disease

The Septins

Volumn , Issue , 2008, Pages 295-317

  Hall, Peter A ^a   Finger, Fern P ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

HIF1alpha; HNA; Infection; MLL; Neoplasia; Neurodegeneration; Septin

Indexed keywords

EID: 84857723901     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470779705.ch14     Document Type: Chapter

References (141)

1. Amir, S., Mabjeesh, N.J. (2007) SEPT9_Vl protein expression is associated with human cancer cell resistance to microtubule disrupting agents. Cancer Biology and Therapy, 6 (12), 1926-31.
2. Amir, S., Wang, R., Matzkin, H. et al. (2006) MSF-A interacts with hypoxia-inducible factor-1 alpha and augments hypoxia-inducible factor transcriptional activation to affect tumorigenicity and angiogenesis. Cancer Research, 66 (2), 856-66.
3. Antonarakis, S. (1998) 10 years of genomics, chromosome 21 and Down syndrome. Genomics, 51, 1-16.
4. Bae, Y.J., Kang, S.J. and Park, K.S. (2007) Drosophila melanogaster Parkin ubiquiti-nates peanut and septin1 as an E3 ubiquitin-protein ligase. Insect Biochemistry and Molecular Biology, 37 (5), 430-39.
5. Barr, A.M., Young, C.E., Sawada, K. et al. (2004) Abnormalities of presynaptic protein CDCrel-1 in striatum of rats reared in social isolation: relevance to neural connectivity in schizophrenia. The European Journal of Neuroscience, 20 (1), 303-7.
6. Barral, Y. and Mansuy, I.M. (2007) Septins: cellular and functional barriers of neuronal activity. Current Biology, 17 (22), R961-63.
7. Bartek, J., Lukas, J. and Bartkova, J. (2007) DNA damage response as an anti-cancer barrier: damage threshold and the concept of 'conditional haploinsufficiency'. Cell Cycle (Georgetown, Tex), 6 (19), 2344-47.
8. van Binsbergen, E., de Weerdt, O. and Buijs, A. (2007) A new subtype of MLL-SEPT2 fusion transcript in therapy-related acute myeloid leukemia with t(2;11) (q37;q23): a case report and literature review. Cancer Genetics and Cytogenetics, 176 (1), 72-75.
9. Blaser, S., Horner, J., Wurmell, P. et al. (2004) The novel platelet septin SEPT8 is an interaction partner of SEPT4. Thrombosis and Haemostasis, 91, 959-66.
10. Borkhardt, A., Teigler-Schlegel, A., Fuchs, U. et al. (2001) An ins(X;11)(q24;q23) fuses the MLL and the Septin 6/KIAA0128 gene in an infant with AML-M2. Genes, Chromosomes and Cancer, 32 (1), 82-88.
11. Burrows, J.F., Chanduloy, S., McIlhatton, M.A. et al. (2003) Altered expression of the septin gene, SEPT9, in ovarian neoplasia. Journal de Psychologie Normale et Pathologique, 201, 581-88.
12. Caltagarone, J., Rhodes, J., Honer, W.G. and Bowser, R. (1998) Localization of a novel septin protein, hCDCrel-1, in neurons of human brain. Neuroreport, 9, 2907-12.
13. Capurso, G., Crnogorac-Jurcevic, T., Milione, M. et al. (2005) Peanut-like 1 (Septin 5) gene expression in normal and neoplastic human endocrine pancreas. Neuroendocrinology, 81 (5), 311-21.
14. Cerveira, N., Correia, C., Bizarro, S. et al. (2006) SEPT2 is a new fusion partner of MLL in acute myeloid leukemia with t(2;11)(q37;q23). Oncogene, 25 (45), 6147-52.
15. Chacko, A., Hyland, P.L., McDade, S.S. et al. (2005) SEPT9_v4 expression induces morphological change, increased motility and disturbed polarity. The Journal of Pathology, 206 (4), 458-65.
16. Chance, P.F. (2006) Inherited focal, episodic neuropathies: hereditary neuropathy with liability to pressure palsies and hereditary neuralgic amyotrophy. Neuromolecular Medicine, 8 (1-2), 159-74.
17. Cheon, M.S., Fountoulakis, M., Dierssen, M. et al. (2001) Expression profiles of proteins in fetal brain with Down syndrome. Journal of Neural Transmission. Supplementum, 61, 311-19.
18. Choi, P., Snyder, H., Petrucelli, L. et al. (2003) SEPT5_v2 is a parkin-binding protein. Brain research. Molecular Brain Research, 117, 179-89.
19. Collins, R.F., Schreiber, A.D., Grinstein, S. and Trimble, W.S. (2002) Syntaxins 13 and 7 function at distinct steps during phagocytosis. Journal of Immunology, 169, 3250-56.
20. Cook, J.D., Davis, B.J., Cai, S.L. et al. (2005) Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance. Proceedings of the National Academy of Sciences of the United States of America, 102, 8644-49.
21. Cossart, P., Pizarro-Cerda, J. and Lecruit, M. (2003) Invasion of mammalian cells by Listeria monocytogenes: functional mimicry to subvert cellular functions. Trends in Biological Sciences, 13, 23-31.
22. Cossart, P. and Sansonetti, P.J. (2004) Bacterial invasion: the paradigms of enteroin-vasive pathogens. Science, 304, 242-48.
23. Craven, R.A., Hanrahan, S., Totty, N. et al. (2006a) Proteomic identification of a role for the von Hippel Lindau tumour suppressor in changes in the expression of mitochondrial proteins and septin 2 in renal cell carcinoma. Proteomics, 6 (13), 3880-93.
24. Craven, R.A., Stanley, A.J., Hanrahan, S. et al. (2006b) Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma. Proteomics, 6 (9), 2853-64.
25. Dong, Z., Ferger, B., Paterna, J.C. et al. (2003) Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the Parkin-target-protein, CDCrel-1. Proceedings of the National Academy of Sciences of the United States of America, 100, 12438-43.
26. Elhasid, R., Sahar, D., Merling, A. et al. (2004) Mitochondrial pro-apoptotic ARTS protein is lost in the majority of acute lymphoblastic leukemia patients. Oncogene, 23, 5468-75.
27. Engidawork, E., Gulesserian, T., Fountoulakis, M. and Lubec, G. (2003) Aberrant protein expression in cerebral cortex of fetus with Down syndrome. Neuroscience, 122, 145-54.
28. Finger, F.P., Kopish, K.R. and White, J.G. (2003) A role for septins in cellular and axonal migration in C. elegans. Developmental Biology, 261, 220-34.
29. Frischknecht, F. and Way, M. (2001) Surfing pathogens and the lessons learned for actin polymerisation. Trends in Cell Biology, 11, 30-38.
30. Fu, J.F., Liang, D.C., Yang, C.P. et al. (2003) Molecular analysis of t(X;11)(q24;q23) in an infant with AML-M4. Genes, Chromosomes and Cancer, 38, 253-59.
31. Fujishima, K., Kiyonari, H., Kurisu, J. et al. (2007) Targeted disruption of Sept3, a heteromeric assembly partner of Sept5 and Sept7 in axons, has no effect on developing CNS neurons. Journal of Neurochemistry, 102 (1), 77-92.
32. Gadea, G., Lapasset, L., Gauthier-Rouviere, C. and Roux, P. (2002) Regulation of Cdc42-mediated morphological effects: a novel function for p53. The EMBO Journal, 21 (10), 2373-82.
33. Gandhi, S. and Wood, N.W. (2005) Molecular pathogenesis of Parkinson's disease. Human Molecular Genetics, 14, 2749-55.
34. Garcia, W., de Araajo, A.P., Neto Mde, O. et al. (2006) Dissection of a human septin: definition and characterization of distinct domains within human SEPT4. Biochemistry, 45 (46), 13918-31.
35. Garcia, W., Araujo, A.P., Lara, F. et al. (2007) An intermediate structure in the thermal unfolding of the GTPase domain of human Septin 4 (SEPT4/Bradeion-beta) forms amyloid-like filaments in vitro. Biochemistry, 46, 11101-9.
36. Goedert, M. and Spillantini, M.G. (2006) A century of Alzheimer's disease. Science, 314, 777-81.
37. Gonzàlez-Novo, A., Labrador, L., Jimanez, A. et al. (2006) Role of the septin Cdc10 in the virulence of Candida albicans. Microbiology and Immunology, 50 (7), 499-511.
38. Gonzalez, M.E., Peterson, E.A., Privette, L.M. et al. (2007) High SEPT9_vl expression in human breast cancer cells is associated with oncogenic phenotypes. Cancer Research, 67 (18), 8554-64.
39. Gottfried, Y., Rotem, A., Klein, E. and Larisch, S. (2007) The pro-apoptotic ARTS/ Sept4 protein is significantly reduced in post-mortem brains from schizophrenic patients. Schizophrenia Research, 96, 257-66.
40. Gottfried, Y., Rotem, A., Lotan, R. et al. (2004) The mitochondrial ARTS protein promotes apoptosis through targeting XIAP. The EMBO Journal, 23, 1627-35.
41. Gruenheid, S. and Finlay, B.B. (2003) Microbial pathogenesis and cytoskeletal function. Nature, 422, 775-81.
42. Hall, P.A., Jung, K., Hillan, K.J. and Russell, S.E. (2005) Expression profiling the septin gene family. The Journal of Pathology, 206, 269-78.
43. Hall, P.A. and Russell, S.E.H. (2004) The pathobiology of the septin gene family. The Journal of Pathology, 204, 489-505.
44. Ihara, M., Kinoshita, A., Yamada, S. et al. (2005) Cortical organization by the septin cytoskeleton is essential for structural and mechanical integrity of mammalian spermatozoa. Developmental Cell, 8, 343-52.
45. Ihara, M., Tomimoto, H., Kitayama, H. et al. (2003) Association of the cytoskeletal GTP-binding protein Sept4/H5 with cytoplasmic inclusions found in Parkinson's disease and other synucleinopathies. The Journal of Biological Chemistry, 278,24095-102.
46. Ihara, M., Yamasaki, N., Hagiwara, A. et al. (2007) Sept4, a component of presynaptic Scaffold and Lewy bodies, is required for the suppression of alpha-synuclein neurotoxicity. Neuron, 53 (4), 519-33.
47. Irazoqui, J.E. and Lew, D.J. (2004) Polarity establishment in yeast. Journal of cell science, 117 (Pt 11), 2169-71.
48. Jaeger, J., Koczan, D., Thiesen, H.J. et al. (2007) Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues. Clinical Cancer Research, 13 (3), 806-15.
49. Kadkol, S.S., Bruno, A., Oh, S. et al. (2006) MLL-SEPT6 fusion transcript with a novel sequence in an infant with acute myeloid leukemia. Cancer Genetics and Cytogenetics, 168 (2), 162-67.
50. Kalikin, L.M., Sims, H.L. and Petty, E.M. (2000) Genomic and expression analyses of alternatively spliced transcripts of the MLL septin-like fusion gene (MSF) that map to a 17q25 region of loss in breast and ovarian tumors. Genomics, 63, 165-72.
51. Kang, H.J., Koh, K.H., Yang, E. et al. (2006) Differentially expressed proteins in gastrointestinal stromal tumors with KIT and PDGFRA mutations. Proteomics, 6 (4), 1151-57.
52. Kato, Y., Uzawa, K., Yamamoto, N. et al. (2007) Overexpression of Septin1: possible contribution to the development of oral cancer. International Journal of Clinical Oncology, 31 (5), 1021-28.
53. Khalil, A.A. and James, P. (2007) Biomarker discovery: a proteomic approach for brain cancer profiling. Cancer Science, 98 (2), 201-13.
54. Kim, C.S., Seol, S.K., Song, O.K. et al. (2007) An RNA-binding protein, hnRNP A1, and a scaffold protein, septin 6, facilitate hepatitis C virus replication. Journal of Virology, 81 (8), 3852-65.
55. Kim, D.S., Hubbard, S.L., Peraud, A. et al. (2004) Analysis of mammalian septin expression in human malignant brain tumours. Neoplasia, 6, 168-78.
56. Kim, H.J., Ki, C.S., Park, Q. et al. (2003) MLL/SEPTIN6 chimeric transcript from inv ins(X;11)(q24;q23q13) in acute monocytic leukemia: report of a case and review of the literature. Genes, Chromosomes and Cancer, 38 (1), 8-12.
57. Kinoshita, A., Kinoshita, M., Akiyama, H. et al. (1998) Identification of septins in neurofibrillary tangles in Alzheimer's disease. American Journal of Clinical Pathology, 153, 1551-60.
58. Kinoshita, A., Noda, M. and Kinoshita, M. (2000) Differential localization of septins in the mouse brain. The Journal of Comparative Neurology, 428, 223-39.
59. Kinoshita, M., Kumar, S., Mizoguchi, A. et al. (1997) Nedd5, a mammalian septin, is a novel cytoskeletal component interacting with actin-based structures. Genes and Development, 11, 1535-47.
60. Kinoshita, M. and Takeda, S. (2007) Connecting the dots between septins and the DNA damage checkpoint. Cell, 130 (5), 777-79.
61. Kissel, H., Georgescu, M.M., Larisch, S. et al. (2005) The Sept4 septin locus is required for sperm terminal differentiation in mice. Developmental Cell, 8 (3), 353-64.
62. Kojima, K., Sakai, I., Hasegawa, A. et al. (2004) FLJ10849, a septin family gene, fuses MLL in a novel leukemia cell line CNLBC1 derived from chronic neutrophilic leukemia in transformation with t(4;11)(q21;q23). Leukemia, 18, 998-1005.
63. Koshelev, Y.A., Kiselev, S.L. and Georgiev, G.P. (2003) Interaction of the S100A4 (Mts1) protein with septins Sept2, Sept6, and Sept7 in vitro. Doklady. Biochemistry and Biophysics, 391, 195-97.
64. Kostic, B. and Shaw, P.H. (2000) Isolation and characterisation of sixteen novel p53 response genes. Oncogene, 19, 3978-87.
65. Kremer, B.E., Adang, L.A. and Macara, I.G. (2007) Septins regulate actin organization and cell-cycle arrest through nuclear accumulation of NCK mediated by SOCS7. Cell, 130 (5), 837-50.
66. Kremer, B.E., Haystead, T. and Macara, I.G. (2005) Mammalian septins regulate microtubule stability through interaction with the microtubule-binding protein MAP4. Molecular Biology of the Cell, 16 (10), 4648-59.
67. Kreuziger, L.M., Porcher, J.C., Ketterling, R.P. and Steensma, D.P. (2007) An MLL-SEPT9 fusion and t(11;17)(q23;q25) associated with de novo myelodysplastic syndrome. Leukemia, 31 (8), 1145-48.
68. Kuhlenbaumer, G., Hannibal, M.C., Nelis, E. et al. (2005) Mutations in SEPT9 cause hereditary neuralgic amyotrophy. Nature Genetics, 37 (10), 1044-46.
69. Larisch, S., Yi, Y., Lotan, R. et al. (2000) A novel mitochondrial septin-like protein, ARTS, mediates apoptosis dependent on its P-loop motif. Nature Cell Biology, 2, 915-21.
70. Laudi, S., Steudel, W., Jonscher, K. et al. (2007) Comparison of lung proteome profiles in two rodent models of pulmonary arterial hypertension. Proteomics, 7 (14), 2469-78.
71. Liauw, J., Nguyen, V., Huang, J. et al. (2002) Differential display analysis of prese-nilin 1-deficient mouse brains. Molecular Brain Research, 109, 56-62.
72. Lin, C.W., Tu, P.F., Hsiao, N.W. et al. (2007) Identification of a novel septin 4 protein binding to human herpesvirus 8 kaposin A protein using a phage display cDNA library. Journal of Virological Methods, 143 (1), 65-72.
73. Lindsey, R. and Momany, M. (2006) Septin localization across kingdoms: three themes with variations. Current Opinion in Microbiology, 9, 559-65.
74. Margutti, P., Sorice, M., Conti, F. et al. (2005) Screening of an endothelial cDNA library identifies the C-terminal region of Nedd5 as a novel autoantigen in systemic lupus erythematosus with psychiatric manifestations. Arthritis Research and Therapy, 7 (4), R896-903.
75. Mark, R.E. and Griffin, W.S. (2004) Trisomy 21 and the brain. Journal of Neuropathology and Experimental Neurology, 63, 679-85.
76. May, R.C. and Machesky, L.M. (2002) Phagocytosis and the actin cytoskeleton. Journal of Cell Science, 114, 1061-77.
77. McDade, S.S., Hall, P.A. and Russell, S.E. (2007) Translational control of SEPT9 isoforms is perturbed in disease. Human Molecular Genetics, 16 (7), 742-52.
78. McIlhatton, M.A., Burrows, J.F., Donaghy, P.G. et al. (2001) Genomic organization, complex splicing pattern and expression of a human septin gene on chromosome 17q25.3. Oncogene, 20, 5930-39.
79. Megonigal, M.D., Rappaport, E.F., Jones, D.H. et al. (1998) t(11;22)(q23;q11.2) In acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes. Proceedings of the National Academy of Sciences of the United States of America, 95, 6413-18.
80. Methner, A., Leypoldt, F., Joost, P. and Lewerenz, J. (2001) Human septin 3 on chromosome 22q13.2 is upregulated by neuronal differentiation. Biochemical and Biophysical Research Communications, 283, 48-56.
81. Meuleman, J., Kuhlenbaumer, G., Audenaert, D. et al. (2001) Mutation analysis of 4 candidate genes for hereditary neuralgic amyotrophy (HNA). Human Genetics, 108, 390-93.
82. Miletic, A.V., Swat, M., Fujikawa, K. and Swat, W. (2003) Cytoskeletal remodelling in lymphocyte activation. Current Opinion in Immunology, 15, 261-68.
83. Montagna, C., Lyu, M.S., Hunter, K. et al. (2003) The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines. Cancer Research, 63, 2179-87.
84. Moran, L.B., Croisier, E., Duke, D.C. et al. (2007) Analysis of alpha-synuclein, dopamine and parkin pathways in neuro-pathologically confirmed parkinsonian nigra. Acta Neuropathologica, 113 (3), 253-63.
85. Muller, H.J. (1932) Further Studies on the Nature and Causes of Gene Mutations. Proceedings of the 6th International Congress of Genetics, 213-55.
86. Muñoz-Soriano, V. and Paricio, N. (2007) Overexpression of Septin 4, the Drosophila homologue of human CDCrel-1, is toxic for dopaminergic neurons. The European Journal of Neuroscience, 26 (11), 3150-58.
87. van Nhieu, T., Caron, E., Hall, A. and Sansonetti, P.J. (1999) IpaC induces actin polymerisation and filopodia formation during Shigella entry into epithelial cells. The EMBO Journal, 18, 3249-62.
88. Ono, R., Ihara, M., Nakajima, H. et al. (2005) Disruption of SEPT6, a fusion partner gene of MLL, does not affect ontogeny, leukemogenesis induced by MLL-SEPT6, or phenotype induced by the loss of SEPT4. Molecular and Cell Biology, 25 (24), 10965-78.
89. Ono, R., Taki, T., Taketani, T. et al. (2002) SEPT6, a human homologue to mouse Septin6, is fused to MLL in infant acute myeloid leukemia with complex chromosomal abnormalities involving 11q23 and Xq24. Cancer Research, 62, 333-37.
90. Orimo, A., Gupta, P.B., Sgroi, D.C. et al. (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell, 121, 335-48.
91. Osaka, M., Rowley, J.D. and Zeleznik-Le, N.J. (1999) MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25). Proceedings of the National Academy of Sciences of the United States of America, 96, 6428-33.
92. Pawlak, G. and Helfman, D.M. (2001) Cytoskeletal changes in cell transformation and tumorigenesis. Current Opinion in Genetics and Development, 11 (1), 41-47.
93. Pennington, K., Beasley, C.L., Dicker, P. et al. Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder. (2007) Molecular Psychiatry.
94. Periquet, M., Corti, O., Jacquier, S., Brice, A. (2005) Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synaptic function. The Journal of Neurochemistry, 95 (5), 1259-76.
95. Peterson, E.A., Kalikin, L.M., Steels, J.D. et al. (2007) Characterization of a SEPT9 interacting protein, SEPT14, a novel testis-specific septin. Mammalian Genome, 18 (11), 796-807.
96. Pizarro-Cerda, J., Jonquieres, R., Gouin, E. et al. (2002) Distinct protein patterns associated with Listeria monocytogenes InlA-or InlB-phagosomes. Cellular Microbiology, 4, 101-15.
97. Pollak, D., Fountoulakis, M. and Lubec, G. (2003) The molecular synaptosomal deficit in Down syndrome starts early in life. Neuroembryology, 2, 143-46.
98. Qi, M., Yu, W., Liu, S. et al. (2005) Septin1, a new interaction partner for human serine/threonine kinase aurora-B. Biochemical and Biophysical Research Communications, 336 (3), 994-1000.
99. Robertson, C., Church, S.W., Nagar, H.A. et al. (2004) Properties of SEPT9 isoforms and the requirement for GTP binding. Journal de Psychologie Normale et Pathologique, 203, 519-27.
100. Russell, S.E., Hall, P.A. (2005) Do septins have a role in cancer? British Journal of Cancer, 93 (5), 499-503.
101. Russell, S.E., McIlhatton, M.A., Burrows, J.F. et al. (2000) Isolation and mapping of a human septin gene to a region on chromosome 17q, commonly deleted in sporadic epithelial ovarian tumors. Cancer Research, 60, 4729-34.
102. Sager, R. (1997) Expression genetics in cancer: shifting the focus from DNA to RNA. Proceedings of the National Academy of Sciences of the United States of America, 94 (3), 952-55.
103. Sakai, K., Kurimoto, M., Tsugu, A. et al. (2002) Expression of Nedd5, a mammalian septin, in human brain tumors. Journal of Neurooncology, 57, 169-77.
104. Scott, M., Hyland, P., McGregor, G. et al. (2005) Multimodality expression profiling shows SEPT9 to be over-expressed in a wide range of human tumours. Oncogene, 24 (29), 4688-700.
105. Scott, M., McCluggage, W.G., Hillan, K.J. et al. (2006) SEPT9 transcript expression profiling in epithelial ovarian neoplasia defines borderline tumours as a distinct category. International Journal of Cancer, 118 (5), 1325-29.
106. Shih, L.Y., Liang, D.C., Fu, J.F. et al. (2006) Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement. Leukemia, 20, 218-23.
107. Sibley, L.D. (2004) Intracellular parasite invasion strategies. Science, 304, 248-53.
108. Sirajuddin, M., Farkasovsky, M., Hauer, F., Kühlmann, D., Weyand, M., Stark, H. and Wittinghofer, A. (2007) Structural insight into filament formation by mammalian septins. Nature, 449 (7160), 311-15.
109. Sirajuddin, M., Farkasovsky, M., Hauer, F. et al. (2007) Structural insight into filament formation by mammalian septins. Nature, 449, 311-15.
110. Slany, R.K. (2005) When epigenetics kills: MLL fusion proteins in leukemia. Hematological Oncology, 23 (1), 1-9.
111. Slater, D.J., Hilgenfeld, E., Rappaport, E.F. et al. (2002) MLL-SEPTIN6 fusion recurs in novel translocation of chromosomes 3, X, and 11 in infant acute myelomonocytic leukaemia and in t(X;11) in infant acute myeloid leukaemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisome. Oncogene, 21 (30), 4706-14.
112. Smith, A.E. and Helenius, A. (2004) How viruses enter animal cells. Science, 304, 237-42.
113. So, C.W., Lin, M., Ayton, P.M. et al. (2003) Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias. Cancer Cell, 4, 99-110.
114. Son, J.H., Kawamata, H., Yoo, M.S. et al. (2005) Neurotoxicity and behavioral deficits associated with Septin 5 accumulation in dopaminergic neurons. Journal of Neurochemistry, 94 (4), 1040-53.
115. Sorensen, A.B., Lund, A.H., Ethelberg, S. et al. (2000) Sint1, a common integration site in SL3-3-induced T-cell lymphomas, harbors a putative proto-oncogene with homology to the septin gene family. Journal of Virology, 74, 2161-68.
116. Spiliotis, E.T., Kinoshita, M. and Nelson, W.J. (2005) A mitotic septin scaffold required for mammalian chromosome congression and segregation. Science, 307, 1781-85.
117. Steels, J.D., Estey, M.P., Froese, C.D. et al. (2007) SEPT12 is a component of the mammalian sperm tail annulus. Cell Motility and the Cytoskeleton, 64 (10), 794-807.
118. Strehl, S., Konig, M., Meyer, C. et al. (2006) Molecular dissection of t(11;17) in acute myeloid leukemia reveals a variety of gene fusions with heterogeneous fusion transcripts and multiple splice variants. Genes, Chromosomes and Cancer, 45 (11), 1041-49.
119. Sudo, K., Ito, H., Iwamoto, I. et al. (2007) SEPT9 sequence alternations causing hereditary neuralgic amyotrophy are associated with altered interactions with SEPT4/ SEPT11 and resistance to Rho/Rhotekin-signaling. Human Mutation, 28 (10), 1005-13.
120. Tada, T., Simonetta, A., Batterton, M. et al. (2007) Role of septin cytoskeleton in spine morphogenesis and dendrite development in neurons. Current Biology, 17 (20), 1752-58.
121. Takehashi, M., Alioto, T., Stedeford, T. et al. (2004) Septin 3 gene polymorphism in Alzheimer's disease. Gene Expression, 11 (5-6), 263-70.
122. Takehashi, M., Tanaka, S., Stedeford, T. et al. (2004) Expression of septin 3 isoforms in human brain. Gene Expression, 11 (5-6), 271-78.
123. Taki, T., Ohnishi, H., Shinohara, K. et al. (1999) AF17q25, a putative septin family gene, fuses the MLL gene in acute myeloid leukemia with t(11;17) (q23;q25). Cancer Research, 59, 4261-65.
124. Tanaka, M., Kijima, H., Itoh, J. et al. (2002) Impaired expression of a human septin family gene Bradeion inhibits the growth and tumorigenesis of colorectal cancer in vitro and in vivo. Cancer Gene Therapy, 9, 483-88.
125. Tanaka, M., Tanaka, T., Kijima, H. et al. (2001) Characterization of tissue-and cell-type-specific expression of a novel human septin family gene, Bradeion. Biochemical and Biophysical Research Communications, 286, 547-53.
126. Tanaka, M., Tanaka, T., Matsuzaki, S. et al. (2003) Rapid and quantitative detection of human septin family Bradeion as a practical diagnostic method of colorectal and urologic cancers. Medical Science Monitor, 9, 61-68.
127. Tatsumi, K., Taki, T., Taniwaki, M. et al. (2002) The CDCrel-1 gene fused to MLL in de novo acute myeloid leukemia with t(11;22)(q23;q11.2) and its frequent expression in myeloid leukemia cell lines. Genes, Chromosomes and Cancer, 30, 230-35.
128. Vega, I.E. and Hsu, S.C. (2003) The septin protein Nedd5 associates with both the exocyst complex and microtubules and disruption of its GTPase activity promotes aberrant neurite sprouting in PC12 cells. Neuroreport, 14, 31-37.
129. Warenda, A.J., Kauffman, S., Sherrill, T.P. et al. (2003) Candida albicans septin mutants are defective for invasive growth and virulence. Infection and Immunity, 717, 4045-51.
130. Wisniewski, K., Wisniewski, H. and Wen, G. (1985) Occurrence of neuropatholog-ical changes and dementia of Alzheimer's disease in Down syndrome. Annals of Neurology, 17, 278-82.
131. Wood, L.D., Parsons, D.W., Jones, S. et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science, 318 (5853), 1108-13.
132. Wood-Kaczmar, A., Gandhi, S. and Wood, N.W. (2006) Understanding the molecular causes of Parkinson's disease. Trends in Molecular Medicine, 12, 521-28.
133. Xiao, G.H., Shoarinejad, F., Jin, F. et al. (1997) The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis. The Journal of Biological Chemistry, 272, 6097-100.
134. Xie, Y., Vessey, J.P., Konecna, A. et al. (2007) The GTP-binding protein Septin 7 is critical for dendrite branching and dendritic-spine morphology. Current Biology, 17, 1746-51.
135. Xiong, J.W., Leahy, A. and Stuhlmann, H. (1999) Retroviral promoter-trap insertion into a novel mammalian septin gene expressed during mouse neuronal development. Mechanisms of Ageing and Development, 86, 183-91.
136. Xue, J., Tsang, C.W., Gai, W.P. et al. (2004) Septin 3 (G-septin) is a developmentally regulated phosphoprotein enriched in presynaptic nerve terminals. Journal of Neurochemistry, 91, 579-90.
137. Yamamoto, K., Shibata, F., Yamaguchi, M. and Miura, O. (2002) Fusion of MLL and MSF in adult de novo acute myelomonocytic leukemia (M4) with t(11;17)(q23;q25). International Journal of Hematology, 75, 503-7.
138. Yang, J.W., Juranville, J.F., Hager, H. et al. (2005) Molecular diversity of rat brain proteins as revealed by proteomic analysis. Molecular Diversity, 9, 385-96.
139. Yang, J.W., Czech, T., Felizardo, M. et al. (2006) Aberrant expression of cytoskeleton proteins in hippocampus from patients with mesial temporal lobe epilepsy. Amino Acids, 30, 477-93.
140. Ying-Tao, Z., Yi-Ping, G., Lu-Sheng, S. and Yi-Li, W. (2005) Proteomic analysis of differentially expressed proteins between metastatic and non-metastatic human colorectal carcinoma cell lines. European Journal of Gastroenterology and Hepatology, 17, 725-32.
141. Zhang, Y., Gao, J., Chung, K.K.K. et al. (2000) Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein CDCrel-1. Proceedings of the National Academy of Sciences of the United States of America, 97, 13354-59.